The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
申请公布号
WO2016205200(A1)
申请公布日期
2016.12.22
申请号
WO2016US37381
申请日期
2016.06.14
申请人
GENENTECH, INC.;F. HOFFMANN-LA ROCHE AG
发明人
KELLEY, Robert F.;LEONG, Steven R.;LIANG, Wei-Ching;MATHIEU, Mary;POLSON, Andrew G.;WU, Yan;ZHENG, Bing;CHEN, Xiaocheng;CHIU, Ceclila Pui Chi;DENNIS, Mark S.;EBENS, Allen
